| [1] | Cui J, Li F, Shi Z-L. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 2019; 17: 181-192. |
| |
| [2] | Zhou P, Yang XL, Wang Xg, hu B, Zhang L, Zhang W, Si hR, Zhu Y, Li B, huang CL, Chen hD, Chen J, Luo Y, guo h, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao gF, Shi ZL. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579: 270273. |
| |
| [3] | World Health Organization. WHO Situation Report-84 2020 [Available from: https://www.who.int/docs/default- source/coronaviruse/situation-reports/20200527-sitrep-84-covid- 19.pdf?sfvrsn=44f511ab_2. |
| |
| [4] | COVID-19 IgM/IgG Rapid Test. Available online: https://www.biomedomics.com/products/infectiousdisease/covid- 19-rt/ (accessed on 15 June 2020). |
| |
| [5] | Chai X, hu L, Zhang Y, han W, Lu Z, Ke a, Zhou J, Shi g, Fang n, Fan J, Cai J, Fan J, Lan F. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. bioRxiv 2020; 2020.2002.2003.931766. |
| |
| [6] | Liu J, Liu Y, Xiang P, Pu L, Xiong h, Li C, Zhang M, tan J, Xu Y, Song R, Song M, Wang L, Zhang W, han B, Yang L, Wang X, Zhou g, Zhang t, Li B, Wang Y, Chen Z, Wang X. Neutrophil-to-lymphocyte ratio predicts severe illness patients with 2019 Novel Coronavirus in the early stage. medRxiv 2020; 2020. 2002. 2010. 20021584. |
| |
| [7] | Li, Z, Yi, Y, Luo, X, et al. Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis. J Med Virol. 2020; 1-7. |
| |
| [8] | The World’s First 2019-nCoV CLIA Kits Received CE Mark. Available online: http://www.snibe.com/zh_en/en_newsView.aspx?id=576 (accessed on 15 June 2020). |
| |
| [9] | Yang Y, Yang M, Shen C, Wang F, Yuan J, Li J, et al. Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019nCoV infections. MedRxiv 2020: 2020 .02. 11. 20021493. |
| |
| [10] | Boletim Epidemiológico 8. Secretaria de Vigilância em Saúde. Brasília: 2020. |
| |
| [11] | Accelerated Emergency Use Authorization (EUA) Summary Modified Thermo Fisher TaqPath COVID-19 SARS-CoV-2 Test (ORF1ab, N, and S gene detection) (Biocerna). n.d. |
| |
| [12] | He X, Lau EHY, Wu P, Deng X, Wang J, Hao X, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med 2020: 1-4. |
| |
| [13] | Wölfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Müller MA, et al. Virological assessment of hospitalized patients with COVID-2019. Nature 2020: 1-5. |
| |
| [14] | Zhang W, Du RH, Li B, Zheng XS, Yang X Lou, Hu B, et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect 2020; 9: 386-9. |
| |
| [15] | Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y, et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis 2020. |
| |
| [16] | Long, Q., Tang, X., Shi, Q. et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med (2020). |
| |
| [17] | The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020 [J]. China CDC Weekly, 2020, 2(8): 113-122. |
| |
| [18] | Erik Greb. Headache May Predict Clinical Evolution of COVID-19. Medscape. June 19, 2020. Available online: https://www.medscape.com/viewarticle/932637 (Accessed on June 20 June, 2020). |
| |